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Objectives: carotid endoluminal intervention is an alternative to surgery but carries a risk of embolic stroke even with
distal protection devices. We investigated the clinical features and degree of stenosis related to number and size of emboli
during carotid angioplasty.
Design: an experimental ex vivo study.
Materials: an ex vivo pulsatile flow model was used in which temperature, velocity, flow, pressure and viscosity
characteristics were designed to simulate the carotid circulation.
Methods: carotid endarterectomy specimens excised as intact cylinders (n 28) were subjected to a standardised angio-
plasty procedure using radiological guidance. Emboli collected in filters placed distally were counted and sized using
microscopy.
Results: median number of emboli during angioplasty was 133 (range 15±1331). Median size of the largest embolus was
700 microns (range 75±2400). Severity of stenosis correlated with increased maximum size (r 0.55, p 0.012). Statin
therapy > 4 weeks pre-operatively was associated with reduced emboli number and size (54 (range 15±748) vs 247 (range
37±1331) [p 0.023] and 400mm (range 75±2400) vs 1300 mm (range 600±2200) [p 0.022]).
Conclusions: in this model a wide range of emboli number and size were produced. Number and size of embolic particles
were highest in patients with high-grade stenoses not receiving statin therapy.
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Introduction
Endovascular treatment of carotid artery stenosis is a
potential alternative to carotid endarterectomy in the
prevention of stroke. Doubt remains, however, as to
the safety of angioplasty and stenting in this region
due to the risk of distal embolisation, thought to be the
main culprit for the complications of this procedure.
These emboli can be clearly demonstrated using tran-
scranial Doppler1,2 and may be collected in distal pro-
tection filters or in the aspirated blood pooled below a
distal balloon.3±6 The current use of distal protection
devices during carotid endoluminal intervention is
thought to have improved the safety of the procedure
by decreasing the number of emboli entering the distal
cerebral circulation,7 shown using ex vivo models3,8
and TCD9 but even with these devices the risk of
embolic stroke remains.
Retrospective reviews have highlighted some
patient and angiographic factors that predispose to
an increased risk of stroke such as advanced age,
symptomatic lesions, hypertension and the presence
of long or multiple stenoses.10±12 Echolucent plaques
may also be at increased risk of embolisation.13,14
There is a need to further determine the potential for
embolisation and establish which patients are at
greater risk from embolic stroke during carotid endo-
vascular intervention.
Ex vivo angioplasty models8,13,15,16 may be used to
study carotid endoluminal intervention and the
behaviour of carotid plaques. The risk of stroke may
reasonably be assumed to be higher from plaques that
produce a greater number and size of emboli. This has
been demonstrated in vivo, where the maximum size
of emboli retrieved from the pooled blood below a
distal balloon correlates well with the number of peri-
procedural neurological events.17 Previously used
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models have been set up using simple haemodynamic
parameters with non-pulsatile flow and constant
pressure.8,13,15 Constant pressure across the lesion
produces varying flows throughout the procedure,
which may have implications for emboli production
and the stage of the procedure that emboli are col-
lected. Temperature and viscosity are other para-
meters that may have implications for the embolic
potential of atherosclerotic plaques. It is known that
the lipid core of plaques, a common source of embo-
lisation, is highly variable in its composition.18 The
behaviour of lipids is dependant on temperature and
may well affect the number and size of emboli
produced.
Earlier ex vivo models did not look at the effect of
pharmacological agents, which have recently been
demonstrated to have a potentially stabilising effect
on atherosclerotic plaques.19 In particular, the use of
statins in reducing spontaneous cardiovascular events
has received a great deal of attention, but the effect of
statin therapy on embolisation during endovascular
intervention has not been investigated.
We have studied the role of clinical factors and
degree of stenosis in determining the embolic poten-
tial of carotid atherosclerotic plaques and the effect of
statin therapy on embolisation in a pulsatile, tempera-
ture controlled ex vivo model of carotid angioplasty.
Materials and Methods
Patients
Twenty-eight consecutive patients were included
within the study. Patient demographics and clinical
details including cardiovascular risk factors and
details of drug therapy were prospectively collected
and are noted in Table 1. We defined symptomatic
patients as those with clinical symptoms of a cerebro-
vascular accident (CVA), transient ischaemic attack
(TIA) or amaurosis fugax and recent symptoms as
those occurring within one month prior to surgery.
Brain imaging (computerised tomography (CT) or
magnetic resonance imaging (MRI)) abnormalities
and the percentage stenosis using duplex examination
was recorded from pre-operative tests.
Carotid endarterectomy specimen collection and
preparation
Our carotid endarterectomy technique was modified
so that plaques were removed as an intact cylinder
avoiding incision into the core of the plaque. This was
to avoid increased embolisation during the angio-
plasty procedure caused by a split in a soft plaque
and so that the circumferential stresses of angioplasty
could be mimicked in the model. This technique has
been described previously.20,21 Briefly, after exposure
and control of the carotid artery, a 0.5 mm arteriotomy
was performed at the proximal and distal extent of the
plaque and the adventitia was incised over the plaque
(Fig. 1a). The plaque was endarterectomised without
incision into the core of the plaque or the lumen
(Fig. 1b). If a shunt needed to be placed, it was placed
through the second arteriotomy at the distal extent of
the plaque into the ICA before endarterectomy allow-
ing the operator time to remove the plaque carefully
and precisely.
Specimens were immediately placed into an anti-
biotic laden transport medium (Hanks balanced salt
solution containing 50 mM HEPES buffer, 0.075%
sodium bicarbonate, 200 U/ml penicillin G sodium,
200 mg/ml streptomycin sulphate, 200 mg/ml kana-
mycin, 2.5 mg/ml amphotericin B) and stored at 4C
for less than 6 days. Angioplasty was performed with-
in the angiography suite as soon as time allowed.
The carotid plaque was invested into a 8 mm
expanded polytetrafluoroethelyene (PTFE) graft
(Boston Scientific, U.K. and Bard International, U.K.)
prior to inclusion into the model (Fig. 1c). Expanded
PTFE has previously been shown to have similar
elastic properties to that of carotid artery adventitia.13
The endarterectomy specimen was placed into the graft
Table 1. Patient demographics and clinical information
(28 patients).
Demography
Women 8 (29%)
Men 20 (71%)
Age 69.5 years
(range 51±85)
Details of symptoms
Symptomatic within 6 months 16 (57%)
Recent symptoms 9 (32%)
CVA 7 (25%)
TIA 7 (25%)
Amaurosis fugax 7 (25%)
Posterior circulation 2 (7%)
Risk factors
Smoking 27 (96%)
Hypertension 21 (75%)
Family history of vascular disease 8 (29%)
Diabetes 7 (25%)
Drug therapy
Statin therapy> 4 weeks 20 (71%)
Aspirin therapy 21 (75%)
Investigations
Percentage ipsilateral
ICA stenosis (duplex)
83.75%
(range 62.5±97.5%)
Lesion on brain imaging 21/26 (81%)
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via a londitudinal incision. Tissue glue was used cir-
cumferentially, but sparingly, around the common
carotid artery (CCA) to ensure flow was directed
into the lumen of the plaque. The PTFE graft was
wrapped around the plaque and closed using a 6/0
polypropylene suture so that the graft was closely
applied to the plaque but not constricting the lumen.
The external carotid artery (ECA) was not included
within the PTFE graft and was suture ligated. Leakage
from the suture line was minimized using a silicone-
based sealant.
Pulsatile angioplasty model
A 50% saline and 50% glycerol solution warmed to
37C was introduced into the model through a 40-
micron filter. This fluid has a viscosity similar to that
of whole blood. A continuous flow circuit was con-
structed from semi-rigid tubing taking the perfusate
from a reservoir, through the pump, the lumen of the
carotid endarterectomy specimen, a series of filters of
different sizes and back to the reservoir. A proximal
side arm allowed introduction of an endovascular
sheath. Fluid returned to the pump via a reservoir
system to remove air. This circuit is shown diagram-
matically in Figure 2.
Pulsatile flow was established around the circuit
using a modified peristaltic pump. Flow, pressure
and velocity characteristics of the model were vali-
dated using a 77.5% stylised stenosis constructed
from silicone within a PTFE graft. Proximal to this
stenosis the pulse rate was 60 cycles/min, systolic
pressure was 135 mmHg, flow rate through the
lumen of the stenosis was 170 ml/min and peak sys-
tolic velocity proximal to the stenosis was 55 cm/s.
Continuous forward flow of fluid with no diastolic
backflow can be directly visualised in the model.
These parameters were used throughout the study.
Standardised angioplasty procedure
Angioplasty of specimens took place within the angio-
plasty suite at a median of 4 days after operation
(range 0±6 days) after removal from antibiotic storage
medium and warming to 37C. All procedures were
carried out by one of two consultant vascular inter-
ventional radiologists, with wide experience in gen-
eral endovascular procedures and training in carotid
endovascular procedures. Initially, a 10-min perfusion
period was used to `` flush'' the plaque so that clinically
irrelevant amorphous material and post-operative clot
were cleared from the lumen. Filters were changed
and the vessel perfused during a control (pre-
intervention) period of 10 min. This was followed by
a 10-min period to allow passage of the guide wire.
Initially contrast was injected via a catheter placed
proximal to the plaque and subtraction images
acquired (Fig. 3a). After imaging of the plaque the
stenosis was traversed using a 0.035 inch diameter
guide wire. This guide wire was used in preference
to a smaller diameter wire due to difficulty in entering
the lumen of the plaque with the thinner, more flexible
wire in initial trials, thought to be due to the artificial
shelf produced between the lumen of the PTFE and
carotid specimen. To standardize the procedure for all
Fig. 1. This figure illustrates the preparation of carotid endarterect-
omy specimens for inclusion into the flow model. (a) The carotid
endarterectomy technique was modified so that the adventitia of the
artery was incised without incision into the core or lumen of the
plaque (a Pruitt±Inahara shunt is in place). (b) A circumferentially
intact endarterectomy specimen. (c) The carotid specimen was
invested into a PTFE graft, closed using a 6/0 polypropylene suture.
The external carotid artery is also closed.
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plaques we elected to use the 0.035 inch guide wire. A
catheter was used to change the wire to a 0.014 inch
diameter wire, compatible with the carotid angio-
plasty balloons and the 10-min collection period
completed. In the last stage of the procedure a
6 mm 4 cm angioplasty balloon (Boston Scientific,
U.K.) was positioned at the stenosis and inflated two
minutes after the start of the period to 12 kPa over 15 s
using a balloon inflation device. The balloon was
inflated for 30 s and subsequently deflated. The
10-min collection period was completed, during which
time completion images were acquired (Fig. 3b).
Emboli collection and assessment
Stainless steel reusable filters (Endecotts Ltd, U.K.)
were placed in series in the circuit immediately distal
to the plaque. Three separate filters of 1 mm, 200
micron and 75-micron pore sizes were used to collect
emboli of differing sizes. A 1 mm pore size filter was
used as this corresponds to the diameter of the pri-
mary branches of the middle cerebral artery (MCA).
Post mortem studies of the branches of the MCA have
shown that 60% of branches have an intra-luminal
diameter of 1 mm or less when measured 1 cm from
the point of origin of the vessel.22 A 200 micron filter,
corresponding to approximately the diameter of per-
forating branches of the anterior cerebral artery
(ACA)23 and terminal cortical branches shown to pro-
duce border zone infarcts when occluded,24 was
employed to trap emboli of sizes 200±1000 microns.
The last filter in the series was a 75 micron filter, to
capture emboli of 75±200 microns, which may be col-
lected when using distal protection device filters.
Filters were individually assessed using a dissection
microscope. The investigator was aware of patient
details but blinded to the stage from which the filter
was obtained. Emboli over 200 microns in length were
sized into 200-micron groups using the pores on the
200-micron filter as a grid. Emboli were deliberately
not manipulated and therefore left on the filter and
measured in this way. For each stage in the procedure,
number and maximum length of the emboli were
recorded and used for analysis.
Statistical analysis
Continuous variables are expressed as median and
interquartile range (IQR), with maximum and min-
imum values. Freidman's ANOVA and subsequently
the Wilcoxon signed-rank tests were used to compare
stages of the procedure. The Mann±Whitney U-test
and Spearman's Rank correlation coefficient were
used to examine the relationship between clinical fac-
tors, severity of stenosis and emboli production. Stat-
istical significance was assumed if p< 0.05.
Results
Twenty-seven carotid endarterectomy specimens were
collected without incision into the lumen or core of the
  
 
 
Fig. 2. Diagrammatic representation of the carotid angioplasty model.
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plaque. The other specimen was a soft plaque that was
inadvertently damaged during removal. Twenty-five
of the remaining 27 specimens were successfully
angioplastied. One procedure was abandoned, as it
was impossible to pass the guide wire into the
lumen of the specimen under radiological guidance.
This was thought to be secondary to an artificially
created flap at the PTFE-specimen boundary. One
Fig. 3. Digital subtraction images of the carotid endarterectomy specimen within a PTFE graft. (a) A pre-intervention image showing the
stenosis within the internal carotid artery. (b) A post-angioplasty image showing dilation of the stenosis. The guide wire remains in place.
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other procedure was unsuccessful as the guide wire
passed between PTFE and the specimen and not into
the lumen of the plaque. Macroscopic evaluation of
plaques following angioplasty showed that in all of
the 25 successful cases the angioplasty balloon was
inflated within the lumen.
Of the 25 specimens angioplastied in this study,
20 duplex and ex-vivo angiogram images could be
directly compared to determine a correlation between
stenosis measurements between duplex and angio-
gram. The severity of stenosis was determined on
the ex vivo angiogram using the ECST method and
on duplex by velocity criteria. The stenoses from each
method were significantly correlated (Spearman's
rank correlation coefficient 0.61, p 0.004). The dif-
ference in stenosis measurement was less than 10% in
14 of 20, and 15% or less in 19 of 20 readings.
Emboli were produced during the procedure in all
cases with a wide variation in number and size.
Median total number of emboli (control, guide wire
and balloon stages) was 133 (IQR 39±304, minimum
15, maximum 1331). Median size of the largest
embolus was 700 microns (IQR 200±1450, minimum
75, maximum 2400). Most emboli were small. Median
number (and range) of emboli within the 75±200
micron, 200±1000 micron and greater than 1000 micron
groups was 115 (IQR 33±237, minimum 14, maximum
979), 22 (IQR 4.5±70.5, minimum 0, maximum 349)
and 0 (IQR 0±1.75, minimum 0, maximum 5). Total
number of emboli during the procedure correlated
closely with maximum size of emboli (r 0.60,
p 0.003)
The number of emboli produced differed between
the three collection periods. Median number (and
range) of emboli for the control period was 9 (IQR
3.5±32.5, minimum 0, maximum 241), for the guide
wire period was 18 (IQR 10.5±127, minimum 6, max-
imum 627) and for the balloon stage was 62 (IQR 20±
148, minimum 6, maximum 827) (Fig. 4). There was a
significant increase in numbers of emboli comparing
control and both interventional stages. However,
although the median number of emboli produced
was higher during the balloon stage, there was no
statistical difference between the number of emboli
collected during guide wire and balloon stages. Simi-
lar results were found when examining maximum
emboli size for each stage of the procedure (Fig. 5).
Median maximum size of emboli produced (and
range) for the control period was 75 microns (IQR
75±200, minimum 0, maximum 1000), for the guide
wire period was 200 microns (IQR 75±1000, minimum
75, maximum 2400) and for the balloon stage was 600
microns (IQR 75±1400, minimum 75, maximum 2200).
The maximum embolus size was increased in
interventional compared to control periods. Again,
although the median maximum size was greater in
the balloon stage when compared to guide wire
stage this result was not statistically significant.
Analysis of the relationship between patient or pla-
que factors and emboli number and maximum size
(Table 1) revealed the use of statin therapy for a period
of greater than 4 weeks was associated with a signifi-
cantly decreased median number of emboli (median
54 (IQR 35.5±195 minimum 15, maximum 748) for
those on a statin versus 247 (IQR 139.5±920.25,
minimum 37, maximum 1331)) and maximum size
produced during the procedure (400 microns (IQR
200±1250, minimum 75, maximum 2400) for those on
Fig. 4. Median number and interquartile range of emboli collected
during control, guide wire passage and balloon stages of the angio-
plasty procedure using carotid endarterectomy specimens in a pul-
satile ex vivo model. Comparison between groups was performed
using the Wilcoxon signed-rank test. Guide wire versus Control
period p 0.01. Balloon versus Control period p< 0.001.
Fig. 5. Median maximal size and interquartile range of emboli col-
lected during control, guide wire passage and balloon stages of the
angioplasty procedure using carotid endarterectomy specimens in a
pulsatile ex vivo model. Statistical analysis was performed using the
Wilcoxon signed-rank test. Guide Wire versus Control period
(p 0.009). Balloon versus Control period (p 0.007).
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a statin versus 1300 microns (IQR 850±1900, minimum
600, maximum 2200)). These data are shown in
Figure 6a and b. The degree of stenosis (from duplex
examination) correlated with an increased maximum
size of emboli (r 0.55, p 0.012, shown graphically in
Figure 7). The presence of symptoms or recent symp-
toms, mode of presentation (amaurosis fugax, CVA or
TIA), male sex, smoking history, diabetes, family his-
tory, lesion on cerebral imaging and aspirin therapy
did not correlate with total number or maximum
emboli size.
Discussion
An ex vivo model such as this cannot perfectly mimic
the complicated flow and velocity profiles of the
carotid bifurcation, but we have attempted to model
the angioplasty procedure within a pulsatile flow
model using pressure, flow, temperature, and viscos-
ity characteristics similar to that of the internal carotid
artery in man. There are inevitably criticisms that can
be made regarding the model including the issue of
plaque removal and storage. We believe that careful
removal of the plaque in its entirety using the method
described is unlikely to substantially alter the morph-
ology of the plaque. It is possible that storage of the
plaque could affect its stability, however in our study
the number of days the plaque was stored prior to
angioplasty showed no correlation with number or
size of emboli produced. Previous studies have
shown that most biochemical components of the
atherosclerotic plaque remain unchanged with storage
in saline at 4C.25 In addition to inaccuracy that may
occur due to plaque storage, in vivo disruption of the
plaque during crossing with a guide wire or distal
protection device may lead to thrombus formation at
the site and embolisation, which may be clinically
very important. These complications cannot be
mimicked within an ex vivo model. However, we
know from studies of emboli collected proximal to
distal protection devices used in vivo that the vast
majority of emboli are histologically composed of lip-
oid or fibrous tissue from the plaque itself. This would
suggest that the stability of the plaque itself during the
procedure is the most important feature determining
embolisation and justifies study in an ex vivo model.
Fig. 6. (a) Median number and interquartile range of emboli for 25
patients receiving and not receiving statin therapy collected during
angioplasty of carotid endarterectomy specimens in a pulsatile
ex vivo model. A significant difference between the groups was
demonstrated using the Mann±Whitney U-test (p 0.023). (b)
Median maximal size and interquartile range of emboli for 22
patients receiving/not receiving statin therapy collected during
angioplasty (size was only assessed in 22 angioplasties). A signifi-
cant difference between the groups was demonstrated using the
Mann±Whitney U-test (p 0.022).
Fig. 7. The relationship between severity of stenosis (determined by
duplex) and the maximum size of emboli during angioplasty, using
carotid endarterectomy specimens in a pulsatile ex vivo model.
Spearman's Rank Correlation r 0.55, p 0.012.
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The technique used to demonstrate embolisation
during endovascular intervention is a fairly gross rep-
resentation of the stenting procedure that occurs
in vivo. This technique was used to prevent embolisa-
tion being masked by stent insertion and highlight
differences between plaques.
Angelini6 demonstrated a mean of 33 emboli of 1.8±
5043 microns in length captured within a 100 micron
distal filter in 37 stenting procedures in vivo. This
value is comparable to the observations during the
balloon stage of our study, which captured a median
of 62 emboli of 75±2400 microns. An ex vivo study by
Ohki13 used a 120 micron filter to capture a median of
15 emboli of 120±2100 microns during stenting. Given
that a larger filter size was used and stenting has been
shown to produce less emboli than primary angioplasty,
we would expect a lower number from these two stu-
dies. Comparing all three studies the number of emboli
captured seems related to the pore size of the filter.
The size and number of emboli required to produce
clinical stroke is unknown. Study of embolic material
in the pooled blood below distal protection balloons
suggests a maximum particle area greater than
0.8 mm2 was associated with a 60% chance of having
a periprocedural neurologic complication.17 Masuda
has studied atheroemboli in 15 human brains at aut-
opsy where embolisation was caused by various
causes including cardiovascular surgery or catheteri-
zation.24 This work showed that border zone infarcts
were produced when atheromatous emboli composed
mostly of cholesterol crystals occluded terminal cor-
tical branches. The occluded arteries ranged from
50±300 microns in size. Thromboemboli associated
with varying amounts of cholesterol occluded larger
arteries in three of fifteen cases producing arterial
territory infarcts. This work therefore suggests that
small atheromatous emboli are capable of producing
border zone infarcts in the brain. Although it is not
fully understood how the size and number of emboli
relate to stroke risk, the above studies demonstrate
that the size of emboli produced in our study may
well be of clinical significance. The maximum size of
emboli produced our model was 2.4 mm. This size of
embolus could potentially occlude the middle cerebral
artery of some patients and certainly one of the major
side branches of this important artery.
There are other factors governing whether a patient
displays obvious sign of neurological ischaemia as a
result of embolisation. The path of the embolus cannot
be predicted, and most emboli are believed to be
asymptomatic.1 The tolerance of the brain to vascular
occlusion is also influenced by collateralisation of ves-
sels and varies widely between patients. Given this,
it must be remembered that emboli number and
maximum size examined within this study are a sur-
rogate measure for risk of neurological events.
There were significantly greater numbers of larger
emboli produced during the two interventional stages
compared with the control period. There was, how-
ever, no statistical difference between guide wire and
balloon stages. Ohki8 has shown different results in a
previous ex vivo model when examining the efficacy of
a distal protection device showing fewer numbers of
smaller emboli produced during the passage of guide
wire and distal protection device through the lesion
than during stent placement. Another small ex vivo
study15 specifically designed to look at specific stages
within the procedure showed no pattern in emboli
numbers throughout the procedure but suggested
that larger emboli were produced after ballooning.
The similarity between emboli size and number in
each interventional stage may be explained by the
size of guide wire we used and subsequent passage
of a relatively large catheter. These wires and catheters
are not routinely used in carotid endoluminal proce-
dures, but we felt were necessary to standardise the
angioplasty procedure. Secondly it may be that fur-
ther numbers are required in this study to demon-
strate a difference between stages.
Statin therapy for a period of greater than 4 weeks
was associated with reduced emboli number and
maximal size. This relationship may be secondary to
plaque stabilising effects of 3 hydroxy-3-methyl-
glutaryl-coenzyme A (HMG-CoA) reductase inhibitors.
Statins have been shown to decrease the size of the
atherosclerotic lipid core, number of macrophages and
matrix metalloprotienases as well as increasing colla-
gen content and tissue inhibitors of metalloprotei-
nases19,26 which may account for their plaque
stabilising effects. Angiography,27±29 MRI30 and
duplex31 have all demonstrated the influence of sta-
tins on atherosclerotic morphology in vivo. In our
study, increased stabilisation of the plaque may lead
to a reduced tendency to splitting or rupture of the
plaque. Another possibility is that patients on statin
therapy represent a privileged group who have
had superior cardiovascular risk factor management
and features such as hypertension, cholesterol level and
diabetes have been controlled within a close range.
In the coronary circulation there is also evidence
that pre-interventional statin therapy is protective. A
90% decrease in the incidence of creatinine kinase
elevation to three times the upper limit of normal
(currently considered as periprocedural myocardial
infarction) is seen in those patients treated with a
statin for more than one week.32
Cohort studies of patients undergoing coronary
intervention shows that there is an early improvement
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in mortality in those that undergo the procedure
whilst receiving statin therapy.33,34 These observations
were thought to be due to non-lipid lowering effects of
statins such as improvement in endothelial function
and reduction in oxidative stress although potentially
cardiac damage from embolisation may also be
reduced by statin therapy.
The severity of stenosis of the lesion on pre-
operative duplex examination was related to max-
imum emboli size. This finding may be may be sec-
ondary to instability of carotid plaques as the lumen
progressively narrows35 or due to mechanical forces
such as an increased circumferential stress imposed
on the plaque as the plaque volume increases. Thirdly
it may simply be a reflection of a greater plaque
volume, producing proportionally larger emboli.
Conclusions
Within this temperature controlled, pulsatile ex vivo
angioplasty model using human carotid endarterect-
omy specimens, we have demonstrated a wide range
of emboli number and maximum size between pla-
ques. The procedure performed within this model is
different to that performed in patients but has been
standardised for each plaque. Identification of those
plaques that embolise substantially during the pro-
cedure may allow appropriate selection of patients
for surgery and endovascular therapy.
Methods of stabilising the plaque to reduce emboli
size and number may substantially improve the
results of this technique. The relationship between
statin therapy and decreased emboli number and
size in this model may be secondary to plaque stabi-
lising effects of statins, but further studies are required
to test whether statin therapy gives rise to a lower
embolic load in vivo.
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